About Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem
Clinical Trials at Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem
During the past decade, Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on
average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem
According to Clinical.Site data, the most researched conditions in "Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem" are
"Breast Cancer" (4 trials), "Breast Neoplasms" (1 trials), "Early Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Triple-negative Breast Cancer" (1 trials). Many other conditions were trialed in "Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem" in a lesser frequency.
Clinical Trials Intervention Types at Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem
Most popular intervention types in "Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem" are "Drug" (8 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials), "Placebo" (3 trials), "Paclitaxel" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem
The vast majority of trials in "Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem
Currently, there are NaN active trials in "Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".